Revisiting the epidemiology of pertussis in Canada, 1924-2015: a literature review, evidence synthesis, and modeling study
- PMID: 33218317
- PMCID: PMC7678223
- DOI: 10.1186/s12889-020-09854-4
Revisiting the epidemiology of pertussis in Canada, 1924-2015: a literature review, evidence synthesis, and modeling study
Abstract
Background: Disease surveillance is central to the public health understanding of pertussis epidemiology. In Canada, public reporting practices have significantly changed over time, creating challenges in accurately characterizing pertussis epidemiology. Debate has emerged over whether pertussis resurged after the introduction of adsorbed pertussis vaccines (1981-1985), and if the incidence fell to its pre-1985 after the introduction of acellular pertussis vaccines (1997-1998). Here, we aim to assemble a unified picture of pertussis disease incidence in Canada.
Methods: Using publicly available pertussis surveillance reports, we collected, analyzed and presented Canadian pertussis data for the period (1924-2015), encompassing the pre-vaccine era, introduction of vaccine, changes to vaccine technology, and the introduction of booster doses. Information on age began to be reported since 1952, but age reporting practices (full, partial or no ages) have evolved over time, and varied across provinces/territories. For those cases reported without age each year, we impute an age distribution by assuming it follows that of the age-reported cases.
Results: Below the age of 20 years, the adjusted age-specific incidence from 1969 to 1988 is substantially higher than existing estimates. In children < 1 year, the incidence in some years was comparable to that during the 1988-1999 resurgence.
Conclusions: The results presented here suggest that the surge in the average yearly incidence of pertussis that began in 1988 was weaker than previously inferred, and in contrary to the past findings, below age 5, the average yearly incidence of pertussis from 1999 to 2015 (when the incidence dropped again) has been lower than it was from 1969 to 1988.
Keywords: Canada; Epidemiology; Modeling; National surveillance; Pertussis; Pertussis vaccines.
Conflict of interest statement
ET, AT, JL, and AC are employees of Sanofi Pasteur.
Figures



Similar articles
-
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.Pediatr Infect Dis J. 2009 Jun;28(6):521-8. doi: 10.1097/INF.0b013e318199d2fc. Pediatr Infect Dis J. 2009. PMID: 19436236
-
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746. Pediatrics. 2006. PMID: 16950988
-
Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.CMAJ. 2006 Nov 7;175(10):1213-7. doi: 10.1503/cmaj.051637. CMAJ. 2006. PMID: 17098950 Free PMC article.
-
Epidemiology of pertussis.Pediatr Infect Dis J. 2005 May;24(5 Suppl):S10-8. doi: 10.1097/01.inf.0000160708.43944.99. Pediatr Infect Dis J. 2005. PMID: 15876918 Review.
-
Control of pertussis in the world.World Health Stat Q. 1992;45(2-3):238-47. World Health Stat Q. 1992. PMID: 1462658 Review.
References
-
- Anderson RM, May RM. Infectious diseases of humans. 1. Oxford: Oxford University Press; 1991.
-
- CDC, Pertussis (Whooping Cough), https://www.cdc.gov/pertussis/index.html.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous